...Running head: GAP ANALYSIS: INTERSECT INVESTMENTS Gap Analysis: Gene One Stacy Starkes University of Phoenix May 17, 2010 Gap Analysis: Intersect Investments Gene One is a ground-breaking Biotech organization that has been faced with many issues. The organization has been forced to expand at a rapid rate to meet the organizational goals of becoming one of the leading organizations in the biotech industry. In order to compete with the ever increasing biotech industry, the CEO and the board of directors believe that going public within the next three years would be beneficial for the organization. By making the appropriate choices of becoming a publically traded organization, Gene One will bark upon a journey that will help them to revolutionize and to use cutting edge technology of eliminating pesticides on tomatoes and potatoes to meet the organizational goals. The rapid growth rate took the organization from a small $2 million start-up company to more than a $400 million in annual sales. Therefore, by implementing an IPO strategy and implementing other strategic goals will help fulfill the organizations growth target and prove the organization is worthy of its capabilities. In addition, the method of benchmarking can help Gene One to succeed and enable the organization to find the necessary solutions to the most pressing and immediate issues. According to The Benchmarking Exchange (2010), “Benchmarking is the process of measuring an organization's internal processes...
Words: 3263 - Pages: 14
...Problem Solution: Gene One Corporation Gene One is a biotechnology company on the verge of making some concrete decisions that would affect the future of the company and its employees. The purpose of this paper is to analyze the situation that Gene One is currently facing and identify the challenges facing the company and opportunities that might result from dealing with this problem. Situation Background Gene One entered the biotechnology industry in 1996 after the team discovered a groundbreaking gene technology that eradicated diseases in tomatoes and potatoes. This discovery pleased consumers, as they no longer needed to by products tainted by chemicals. It also pleased farmers, as they no longer needed to use pesticides when growing plants. Gene One became very successful and speedily grew into a $400 million company in a period of eight years. Over time, Wall Street began to have an interest in biotechnology and investors are beginning to build confidence in the industry. To keep up with the growing competition and ever changing global market, Gene One would have to keep up with its competition. In order to remain at the forefront of the competition, Gene One’s management team believed that they would have to go public within the next three years. However, in order to be successful in its endeavors, Gene One needs IPO capital for new development, marketing and advertisement. Gene One’s CEO and his Board have devised a clear strategy with the help of...
Words: 2058 - Pages: 9
...Problem Solution: Gene One University of Phoenix March 26, 2007 Problem Solution: Gene One Introduction Gene One entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals. The win-win situation helped Gene One grow to a $400 million company in just eight short years. Sharply rising stock indices on Wall Street indicate a growing interest in biotechnology and leadership changes at the Food and Drug Administration are further enhancing investor confidence in the industry. At Gene One, the CEO and his Board believe that in order to keep pace with demand and realize conservative annual growth targets of 40 percent, Gene One is going to have to go public within the next three years. It is their hope that implementing it will help Gene One realize its growth targets, establish the company as a strong competitor and show Wall Street that Gene One has the leadership and organizational capabilities to succeed as a public entity. In this paper I will analysis some issues and opportunities that Gene One is facing as well as present a situation analysis defining the problems that Gene One needs to address. I will also analysis alternative and optimal solutions as well as identify the risk that in involved. Once all alternatives have been clear I will recommend...
Words: 1625 - Pages: 7
...Running head: PROBLEM SOLUTION: GENEONE Problem Solution: Gene One The basis for my investigation of the problem in the Gene One scenario is the fact that Gene One’s CEO, Don Ruiz and the Board of directors believes that if the company is to continue its growth of 40% each year, the company will have to go public with an initial public offering (IPO) within the next three years. The purpose for this paper is to review Gene One’s decision to become a public company. Taking Gene One public would be a new venture for the senior team members, who realize that, collectively, they have zero experience with IPOs. This paper looks at the issues and opportunities Gene One is facing, stakeholder’s perspective and ethical dilemma, the end-state goals, alternative solutions, a risk assessment and the optimal solution, and last implementation of the plan. Situation Analysis Issue and Opportunity Identification Gene One is a company that entered the biotech industry with groundbreaking gene technology that eradicated diseases in tomatoes and potatoes. In just eight short years, the company grew into the $400 million company that it is today. Past events that have led to Gene One current issues and opportunities are the fact that the company has grown at such a rapid pace that it outgrowing itself. Further, an increase in stock prices is indicative of the growing interest in the biotech industry. Don Ruiz, the company’s CEO, and the board of directors believes that if the company...
Words: 3835 - Pages: 16
...Gene One: Problem Solution and Defense Gene One is a privately owned biotechnology company who is attempting an initial public offering (IPO). During this transition, opportunities within Gene One‘s organizational structure have been made more eminent. This paper uses the Problem Based Learning model the concepts of transformational leadership and organizational culture will be applied to the current internal issues faced by Gene One in the areas of team dynamics, knowledge and leadership style. Gene One is lead by Don Ruiz who has surpassed expectations during its 8-year growth. Don is an intrinsic part of a 5-member team who built the Gene One out of a 2 million-dollar investment. Don’s goal is to position Gene One as an industry leader. In order to acquire large amounts of capital for advanced research and superior product development to meet consumer demand and a grow by 40% per year, Gene One board of directors have decided on an initial public offering (IPO) within a 36 month deadline. Describe the Situation Issue and Opportunity Identification Gene One has several opportunities within the organizations. These opportunities are organizational culture, teamwork, and leadership. A company’s organizational culture is “the basic pattern of shared assumption, values, and beliefs governing the way employees within an organization think about and act on problems and opportunities,” (McShane and Von Glinow, 2005). Gene One must understand how employees' attitudes, feeling, and...
Words: 3053 - Pages: 13
...Gene One is a company that recently enjoyed breakthrough success with a discovery that benefits the plantation and farming industry. This gene technology intervenes with the eradication of disease in tomatoes and potatoes. "As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals." (Gene One Scenario, 2010) The discovery was in the biotech division of the company and was facilitated by Teri Robertson, Gene One's chief technology officer and research scientist. This company is just 8 years old and was started by founder and CEO, Don Ruiz. The discovery is credited for helping Gene One to grow from a $2 million dollar company to the $400 million dollar company of today. The board of directors is convinced that Gene One could become an industry leader and have aspirations of becoming a successful public company. Various leadership changes at the Food and Drug Administration are further enhancing investor confidence in the industry and this has led to the proposal that Gene One is going to have to go public within the next three years in order to keep pace with the demand. According to the local newspaper, the Daily Gazette, the company plans to increase its annual growth and sales by 40%. This is to be done through more gene technology products that will reduce the need for pesticides. This creates the need for more financing to support the new research that will enable Gene One to...
Words: 1670 - Pages: 7
...Gene One is a company that is only eight years old and was started by founder and Chief Executive Officer (CEO), Don Ruiz. Gene One has recently enjoyed innovative success with a discovery that benefits the agricultural farming industry. This gene technology intervenes with the eradication of disease in tomatoes and potatoes. "As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals" (Gene one, 2009). Teri Robertson, Gene One's chief technology officer and research scientist is credited with the discovery in the biotech division of the company. The discovery is acknowledged for helping Gene One to develop from a $2 million dollar company to the current $400 million dollar company of today. Gene One is coming up on an opportunity for their organization with the transition to an initial public offering (IPO). A milestone for any company is the issuance of publicly traded stock. While the motivations for an initial public offering are clear-cut, the means for doing so is complex. The opportunity they have is to develop an effectively performing culture all working towards the same goal. The company is in a transition phase. I believe that Gene One needs transformational leadership to realize the vision of taking the company into the public sector. Transformational leadership requires charisma, motivation, selflessness, and intellectual stimulation. Research on charismatic...
Words: 1677 - Pages: 7
...SCENARIO: Gene One COMPANY OVERVIEW In 1996, Gene One entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals. The win-win situation helped Gene One grow to a $400 million company in just eight short years. Accordingly, sharply rising stock indices on Wall Street indicate a growing interest in biotechnology. And leadership changes at the Food and Drug Administration are further enhancing investor confidence in the industry. At Gene One, the CEO and his Board believe that in order to keep pace with demand and realize conservative annual growth targets of 40 percent, Gene One is going to have to go public within the next three years. The time seems right, but the company needs IPO capital for new development, advertisement, and marketing if it is to remain successful. Working toward a 36-month maximum deadline, the CEO and his Board have devised a clear strategy with the help of key members in the investment community. It is their hope that implementing it will help Gene One realize its growth targets, establish the company as a strong competitor and show Wall Street that Gene One has the leadership and organizational capabilities to succeed as a public entity. THE PLAYERS Don Ruiz, Chief Executive Officer: At age 37, Don became a young entrepreneur...
Words: 5226 - Pages: 21
...Implementing Leadership Change Gene One is a biotechnology company that has had success with engineering foods that are disease free and grow at increased rates. Vegetables such as tomatoes and potatoes have been grown without the use of pesticides and other harmful chemicals. These breakthroughs have changed Gene One from a $2 million start-up company into a $400 million company on the verge of going public. The original members of Gene One are challenged with organizing the company and preparing it for an initial public offering (IPO) on Wall Street. The IPO requires the company to make several changes to the structure of the company’s executive board, marketing strategy, and product invention. Leadership at Gene One must identify weaknesses in management concerning the IPO, and the stress associated with going public. Management is challenged with accomplishing one of the following: 1. Gene One becomes a public company and the goals suggested by the chief executive officer (CEO) are met by adding new people to the existing staff and retaining the team’s culture. 2. Gene One becomes a public company and the goals suggested by the CEO are met by removing people and changing the company’s culture. Both of these options require management to move forward with the IPO and to make stressful decisions concerning the company’s future. Dealing with the stress of the change will determine the success of the IPO. “In an intelligently managed organization...
Words: 1999 - Pages: 8
...Gene One | Options for implementing a Leadership Change | Strategy Change | | [Type the author name] | 5/17/2010 | | Purpose Gene One is a company that invented gene technology to eradicate disease in potatoes and tomatoes. This gene technology eliminates the need for pesticides when growing tomatoes and potatoes. This invention helped Gene One grow from a $2 million to $400 million dollar company in less than eight years. Mr. Ruiz, the CEO of Gene one wanted to increase the company’s revenue by going public by means of Initial Public Offering (IPO) within 3 years. However, Don Ruiz passed away. As a sibling to Mr. Ruiz and a member of the board, my family and I planned a change strategy in order for Mr. Ruiz’s vision to become reality. We will also identify the leadership structure and styles that we will use to carry out Mr. Ruiz’s vision. Vision Our late CEO, Mr. Ruiz was a true visionary and an angel. He was able to implement a new dream in our mind that did not exist. He showed us a picture of the future even though he couldn’t carry it for himself. Our vision is to move this company toward an initial Public offering which will allow us to grow up to 40% in 3 years. This vision should drive each one of us and our goals. In order for this change to happen, we must abide to the rules and regulations of IPO required by the Sarbanes-Oxley act. Sarbanes-Oxley Act requires that an IPO Board to have at least one member with financial experience...
Words: 1667 - Pages: 7
...3/08/11 LDR531 UOP In 1996, Gene One entered the biotech industry with groundbreaking gene technology that eradicated disease in tomatoes and potatoes. As a result, farmers no longer needed to use pesticides when growing these plants and consumers were pleased to buy homegrown products untainted by chemicals. The win-win situation helped Gene One grow to a $400 million company in just eight short years. Accordingly, sharply rising stock indices on Wall Street indicate a growing interest in biotechnology. And leadership changes at the Food and Drug Administration are further enhancing investor confidence in the industry. At Gene One, the CEO and his Board believe that in order to keep pace with demand and realize conservative annual growth targets of 40 percent, Gene One is going to have to go public within the next three years. The time seems right, but the company needs IPO capital for new development, advertisement, and marketing if it is to remain successful. Working toward a 36-month maximum deadline, the CEO and his Board have devised a clear strategy with the help of key members in the investment community. It is their hope that implementing it will help Gene One realize its growth targets, establish the company as a strong competitor and show Wall Street that Gene One has the leadership and organizational capabilities to succeed as a public entity. THE PLAYERS Don Ruiz, Chief Executive Officer: At age 37, Don became a young entrepreneur when he recruited four colleagues...
Words: 921 - Pages: 4
...Gene One Change Strategy Jeffrey Gaspard LDR/531 February 10, 2010 Dr. Albert Smothers Gene One Change Strategy Every company has a strategic plan whether well defined or organized or not. Gene One has decided to change it strategic plan and focus on becoming and seek an IPO (University of Phoenix, Gene One Scenario, 2010). Through these efforts many questions and roadblocks may arise. Gene One has decided to make an aggressive attempt to confront these challenges to help ensure their goals are meet. Anytime a company changes directions it is imperative that they look at all aspects that the particular change activities may cause. To effectively meet the needs of satisfying the change activities that may arrive, a company must have a change strategy in place. Success, oftentimes is not an easy process. What Must Change Individuals throughout a company that manage change activities, are known as change agents (Robbins, Judge, 2007). Change agents are responsible for carrying out the strategies put in place to effectively handle change. Change agents are not always members of management. Don Ruiz, CEO of Gene One has looked to his team to help create a direction in which the change agents of Gene One, including him and his team, will proceed. As a result, Don has held a meeting to let anyone who has suggestions or concerns about the company new plan the opportunity to speak. He and his team will then act on these concerns or suggestions so that all will be on...
Words: 1181 - Pages: 5
...Gene One Fund Raising Change in business is constant. How leaders of organizations analyze whether or not their organization will be able to change with the times is critical to a successful business. Gene One is an extraordinary biotech company led by a dedicated and talented leadership team. The company began with an idea and two million dollars, eight years later the company became the first biotech company to eliminate disease in tomatoes and potatoes through biotechnology and is worth 400 million dollars. The purpose of this paper is to introduce two strategies to secure funding through venture capital or IPO that supports the company's goals to introduce new products and continue meeting 40% growth targets. Venture Capital Pursing venture capital is an important step for a rapidly growing business, especially when not seeking an IPO (Inc., 2010). The technology developed by Gene One is already on the market and the industry is experiencing a high level of investor interest that gives Gene One an advantage in the venture capital market. However, targeting the right investors makes a significant difference. Gene One is targeting investors that align with the research philosophies that facilitate the research and development team without having to worry about any private agendas. The research and development team will continue developing the innovative technologies expected, aiding the organization to realize its growth potential, and meeting the minimum...
Words: 1658 - Pages: 7
...In this paper I will attempt to help Gene One solve their current problems that they are experiencing as a result of poor planning by management with a new IPO strategy. Although I believe that they were looking out for the company’s/employees’ best interest, the lack of a solid game plan has led us to this point where the working relationship between management has failed. While attempting to uncover the optimal solution I will look at the factors that should be considered when evaluating all options. My hopes are to bring to light why one solution is better than the next as it relates to the vision and goals of the company. This will be done by examining evidence from outside sources that have been through similar situations. This solution will be centered on transformational leadership and organizational culture. By identifying the primary causes of the failed strategy’s implementation, I will dissect and attempt to salvage the IPO strategy that Gene One will still need to carry out. In reading this scenario, one thing obvious from the onset; the senior leadership team at Gene One is not all on the same page. Anytime there is a culture change within an organization there will be resistance by some to change. In the case of Gene One they are no more immune than any other company. Evidence of this could be seen from the interactions of Teri and Michelle at the 1st leadership meeting after the board’s approval of the IPO plan. “What’s the matter, Michelle? Not finding enough...
Words: 4848 - Pages: 20
...Gene One Strategy The basis of the business strategy for Gene One has three criteria: 1. 3-yr timetable 2. 40% growth within the prescribed time-table 3. Acquire additional funding so more products can be developed Greg has identified that the Executive Board and the current leaders are not within Sarbanes Oxley Act of 2002 (SOX). The act is a United States Federal Law that set new or enhanced standards for all U.S. public company boards, management and public accounting firms. It is named after sponsors U.S. Senator Paul Sarbanes, Maryland Democrat, and U.S. Representative Michael G. Oxley, Ohio Republican. As a result of SOX, top management must now individually certify the accuracy of financial information. In addition, penalties for fraudulent financial activity are much more severe. Also, SOX increased the independence of the outside auditors who review the accuracy of corporate financial statements, and increased the oversight role of boards of directors.1 The first order of business is to ensure that the composition of the Executive board members is in full compliance with SOX. Michelle, Gene One Chief Financial Officer, has to ensure that the accounting reports also need to be in full compliance with SOX. She has to develop a realistic timeline required to ensure the financial disclosures of Gene One will replicate the purpose of SOX as described in Newsweek by “improving the confidence of fund managers and other investors with regard to the veracity...
Words: 599 - Pages: 3
